Dharmesh Kant of IndiaNivesh has announced Camson Bio Technologies, a small cap, as his latest stock pick. Given his stellar track record in finding winning stocks, we need to keep a hawk eye on Camson
Posts in category Portfolio
Despite 86% Gains (In Just 3M), Meghmani Organics Is Still A Buy: Daljeet Kohli
Meghmani Organics is living up to the promise of being a “classic turnaround story” with “huge upside” by reporting block-buster Q2FY15 results. Daljeet Kohli, the discoverer of the stock, has reiterated his buy call and target price of Rs. 34
Can We Ignore A “Deep Moat” Stock Backed By Rakesh Jhunjhunwala, Radhakishan Damani, Prof. Shivanand Mankekar, Kenneth Andrade & Prashant Jain?
MCX boasts of a galaxy of savvy investors on its rolls who’ve been attracted to it owing to its “deep moat”. We need to keep an eye and also ponder over whether we should join them and share in the riches
Ravi Dharamshi Of ValueQuest Reveals Favourite Stocks In Portfolio
Ravi Dharamshi, Founder & MD of ValueQuest has identified his favourite stocks and discussed them at length
Panasonic Seeks To Scare Punters Away From De-listing Offer
After Ricoh, Fulford & DIC, it is now the turn of Panasonic to try to scare off punters so that it can finish the de-listing of its shares in peace. Will the punters oblige and leave it alone?
Why Did Nandita Agarwal Parker Of Karma Capital Buy Rico Auto?
Nandita Agarwal Parker Of Karma Capital is renowned for her “contrarian” & “value” picks. Her latest stock pick is Rico Auto. We need to keep an eye on the developments
Should We Buy Vaibhav Global Ahead Of Its Q2FY15 results?
Vaibhav Global’s business model of retailing through home TV shopping business model is highly scalable with limited investment. It’s Q1FY15 results got impacted owing to a one-time affair. Q2FY15 is a seasonally weak quarter. However, the management’s assertion that things will be normal in Q3FY15 suggests that we need to look into the matter closely
Should We Buy Or Sell Ajanta Pharma Now?
Ajanta Pharma has been a great wealth-creator stock. It reported robust Q2FY15 results. However, have the valuations run up ahead of fundamentals and should we sell the stock?
Prof. Shivanand Mankekar Makes Bumper Profit & Bets Big Money On Two Top Quality Stocks
Prof. Shivanand Mankekar has raked in huge profits and put a huge chunk of money to work by buying truckloads of two top-quality stocks. We need to pay attention to his strategy
Meet Nandita Agarwal Parker Of Karma Capital & Check Out Her Winning Stock Picks
Nandita Agarwal Parker of Karma Capital is an ace stock picker with Rs. 420 Cr ($70M) in her kitty. We need to keep an eye on her stock picks
Recent Comments